AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Cytomegalovirus seropositivity and C-reactive protein have independent andcombined predictive value for mortality in patients with angiographically demonstrated coronary artery disease - Response
Authors: Muhlestein, JB Horne, BD Carlquist, JF Madsen, TE Bair, TL Pearson, RR Anderson, JL
Citation: Jb. Muhlestein et al., Cytomegalovirus seropositivity and C-reactive protein have independent andcombined predictive value for mortality in patients with angiographically demonstrated coronary artery disease - Response, CIRCULATION, 104(5), 2001, pp. E20-E21
Prospective study of pathogen burden and risk of myocardial infarction or death
Authors: Zhu, JH Nieto, FJ Horne, BD Anderson, JL Muhlestein, JB Epstein, SE
Citation: Jh. Zhu et al., Prospective study of pathogen burden and risk of myocardial infarction or death, CIRCULATION, 103(1), 2001, pp. 45-51
Usefulness of in-hospital prescription of statin agents after angiographicdiagnosis of coronary artery disease in improving continued compliance andreduced mortality
Authors: Muhlestein, JB Horne, BD Bair, TL Li, QY Madsen, TE Pearson, RR Anderson, JL
Citation: Jb. Muhlestein et al., Usefulness of in-hospital prescription of statin agents after angiographicdiagnosis of coronary artery disease in improving continued compliance andreduced mortality, AM J CARD, 87(3), 2001, pp. 257-261
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease
Authors: Horne, BD Muhlestein, JB Carlquist, JF Bair, TL Madsen, TE Hart, NI Anderson, JL
Citation: Bd. Horne et al., Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease, J AM COL C, 36(6), 2000, pp. 1774-1780
A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease
Authors: Anderson, JL Habashi, J Carlquist, JF Muhlestein, JB Horne, BD Bair, TL Pearson, RR
Citation: Jl. Anderson et al., A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease, J AM COL C, 36(4), 2000, pp. 1248-1252
The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease
Authors: Semaan, HB Gurbel, PA Anderson, JL Muhlestein, JB Carlquist, JF Horne, BD Serebruany, VL
Citation: Hb. Semaan et al., The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease, J CARDIO PH, 36(4), 2000, pp. 533-537
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
Authors: Tcheng, JE O'Shea, JC Cohen, EA Pacchiana, CM Kitt, MM Lorenz, TJ Greenberg, S Strony, J Califf, RM Buller, C Cantor, WJ Joseph, DM Kitt, MM Lincoff, AM Madan, M Popma, J Teirstein, P Cohen, E Balleza, L Parsons, P Lui, H Young, J Fox, R Labinaz, M Jelley, J Williams, J Cohen, D Trovato, M Smith, J Henry, P Chisholm, R O'Donnell, D Talley, JD Pacheco, R Timmis, S Muraka, A Mann, T Cubeddu, G Tannenbaum, M Greene, J Santoian, E Wash, M Sheldon, S Pronesti, L Jain, A Alonzo, M Seidelin, P Richards, J Lopez, M Dittenber, R Johnson, K Levine, G Maresh, K Ferrando, T Sarembock, I Snyder, L Kieval, J Herlan, L Miller, M Bembridge, D Nair, R Hickel, L Kiernan, F Murphy, D Cloutier, J Conn, E Beardsley, J Ritchie, M Cragen, D Jafar, MZ Counihan, P Rosenfelder, D Ducas, J Montebruno, L Carere, R Radons, B Williams, L Owens, W Dougal, R Feldman, R Audrain, D Karamali, A Smith, M Blankenship, J Demko, SL Thompson, M Gacoich, G Chiodo, V Noll, P Ledley, G Miller, C Felten, W Garner, B Chandler, AB Easler, P Albin, G Page, A Maddox, W Allen, S Gilchrist, I Moore, R Zimmerman, H Curtis, M Hildebrand, K Greene, R Healy, E Meengs, W Carson, D George, J Roncevich, T Aharonian, V Browning, R Kostuk, W Carr, S Feit, F Gostomsky, B Butman, S Hannah, E Hassel, CD Hartley, D Shook, T Hiller-Mullin, S Brill, D Dillion, M Armstrong, B Kerns, D Pichard, A Okubagzi, P Nasser, T Driver, L Garrett, J Boltey, L Stouffer, G Potter, M Amidon, T Eggert, S Taussig, A Potter, K Natarajan, M Tartaglia, C Werner, J Dunlap, T Harrold-Runge, P Davidson, C Goodreau, L Herzog, W Calamunci, N Slater, A Tormey, D Phillips, W White, D Sridhar, K White, J Goodman, D Buchbinder, M Nasser, V Rapeport, K Vorman, P Weiner, B Borbone, M Shadoff, N Paap, C Rehman, A Haag, E Burchenal, J Kioussopoulos, K Senior, D Senior, J Piana, R Kirshenbaum, J Chan, S Chowdry, A Kraft, P Clark, V Fox, M Deutsch, E Shannon, T Quesada, R Brotherton, J Murrin, C Cinderella, J Hearne, S Seefried, V Farah, T Pakstis, D Bartolet, B Bond, C Debarardinis, C Montory, D Smith, G Gray, D Phillips, P Hathaway, S Manoukian, S Patrick, C Yakubov, S Brooks, J Block, P Block, B Muhlestein, JB Kim, S Shalev, Y Schmidt, W Resar, J Citro, K Stine, R Zumbuhl, J Moreyra, A Kreiger, S Berger, P Cannon, CP Fisher, L Hasselblad, V Foster, A Joseph, D Madan, M McLendon, C Rund, M Tillery, N Wood, F Mahaffey, KW Irwin, C Kulick, D Johnson, N Chen, J Greenberg, S Hogeboom, C Lorenz, TJ Terifay, R Strony, J Veltri, E
Citation: Je. Tcheng et al., Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, LANCET, 356(9247), 2000, pp. 2037-2044
Chronic infection and coronary artery disease
Authors: Muhlestein, JB
Citation: Jb. Muhlestein, Chronic infection and coronary artery disease, MED CLIN NA, 84(1), 2000, pp. 123
Chlamydia pneumoniae-induced atherosclerosis in a rabbit model
Authors: Muhlestein, JB
Citation: Jb. Muhlestein, Chlamydia pneumoniae-induced atherosclerosis in a rabbit model, J INFEC DIS, 181, 2000, pp. S505-S507
The ACADEMIC study in perspective (azithromycin in coronary artery disease: Elimination of myocardial infection with chlamydia)
Authors: Anderson, JL Muhlestein, JB
Citation: Jl. Anderson et Jb. Muhlestein, The ACADEMIC study in perspective (azithromycin in coronary artery disease: Elimination of myocardial infection with chlamydia), J INFEC DIS, 181, 2000, pp. S569-S571
Collaborative multidisciplinary workshop report: Clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovasculardisease
Authors: Rosen, H Muhlestein, JB Bartlett, J Chen, S Chikami, G Corson, M Shah, PK Gurfinkel, E Handsfield, H Jackson, L Knirsch, C Kronmal, R McCutchan, JA Shea, S
Citation: H. Rosen et al., Collaborative multidisciplinary workshop report: Clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovasculardisease, J INFEC DIS, 181, 2000, pp. S582-S584
Cytomegalovirus seropositivity and C-reactive protein have independent andcombined predictive value for mortality in patients with angiographically demonstrated coronary artery disease
Authors: Muhlestein, JB Horne, BD Carlquist, JF Madsen, TE Bair, TL Pearson, RR Anderson, JL
Citation: Jb. Muhlestein et al., Cytomegalovirus seropositivity and C-reactive protein have independent andcombined predictive value for mortality in patients with angiographically demonstrated coronary artery disease, CIRCULATION, 102(16), 2000, pp. 1917-1923
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease - Primary clinical results of the ACADEMIC study
Authors: Muhlestein, JB Anderson, JL Carlquist, JF Salunkhe, K Horne, BD Pearson, RR Bunch, TJ Allen, A Trehan, S Nielson, C
Citation: Jb. Muhlestein et al., Randomized secondary prevention trial of azithromycin in patients with coronary artery disease - Primary clinical results of the ACADEMIC study, CIRCULATION, 102(15), 2000, pp. 1755-1760
Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease
Authors: Anderson, JL Muhlestein, JB Horne, BD Carlquist, JF Bair, TL Madsen, TE Pearson, RR
Citation: Jl. Anderson et al., Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease, CIRCULATION, 102(11), 2000, pp. 1227-1232
Randomized trial of contrast media utilization in high-risk PTCA - The COURT trial
Authors: Davidson, CJ Laskey, WK Hermiller, JB Harrison, JK Matthai, W Vlietstra, RE Brinker, JA Kereiakes, DJ Muhlestein, JB Lansky, A Popma, JJ Buchbinder, M
Citation: Cj. Davidson et al., Randomized trial of contrast media utilization in high-risk PTCA - The COURT trial, CIRCULATION, 101(18), 2000, pp. 2172-2177
Chlamydia pneumoniae in coronary artery disease - Response
Authors: Anderson, JL Muhlestein, JB Carlquist, J Allen, A Trehan, S Nielson, C Hall, S Brady, J Egger, M Horne, B Lim, T
Citation: Jl. Anderson et al., Chlamydia pneumoniae in coronary artery disease - Response, CIRCULATION, 101(12), 2000, pp. E118-E119
Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease
Authors: Semaan, HB Gurbel, PA Anderson, JL Muhlestein, JB Carlquist, JF Horne, BD Serebruany, VL
Citation: Hb. Semaan et al., Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease, CARDIOLOGY, 93(1-2), 2000, pp. 7-10
Post-hospitalization management of high-risk coronary patients
Authors: Muhlestein, JB
Citation: Jb. Muhlestein, Post-hospitalization management of high-risk coronary patients, AM J CARD, 85(5A), 2000, pp. 13B-20B
Evaluation of chest pain suspicious for acute coronary syndrome: Use of anaccelerated diagnostic protocol in a chest pain evaluation unit - Discussion
Authors: Baron, SB Kirk, JD Muhlestein, JB Schorer, SJ
Citation: Sb. Baron et al., Evaluation of chest pain suspicious for acute coronary syndrome: Use of anaccelerated diagnostic protocol in a chest pain evaluation unit - Discussion, AM J CARD, 85(5A), 2000, pp. 49B-49B
Genetics of coronary heart disease: Current knowledge and research principles
Authors: Winkelmann, BR Hager, J Kraus, WE Merlini, P Keavney, B Grant, PJ Muhlestein, JB
Citation: Br. Winkelmann et al., Genetics of coronary heart disease: Current knowledge and research principles, AM HEART J, 140(4), 2000, pp. S11-S26
Cardiac abnormalities in hemochromatosis
Authors: Muhlestein, JB
Citation: Jb. Muhlestein, Cardiac abnormalities in hemochromatosis, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, 2000, pp. 297-311
Routine stenting or provisional stenting: Which is better? A look at presently existing data
Authors: Muhlestein, JB Maycock, CA
Citation: Jb. Muhlestein et Ca. Maycock, Routine stenting or provisional stenting: Which is better? A look at presently existing data, J INTERV CA, 12(5), 1999, pp. 389-394
Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction
Authors: Anderson, JL Muhlestein, JB Habashi, J Carlquist, JF Bair, TL Elmer, SP Davis, BP
Citation: Jl. Anderson et al., Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction, J AM COL C, 34(6), 1999, pp. 1778-1783
Association of lipoprotein lipase gene polymorphisms with coronary artery disease
Authors: Anderson, JL King, GJ Bair, TL Elmer, SP Muhlestein, JB Habashi, J Mixson, L Carlquist, JF
Citation: Jl. Anderson et al., Association of lipoprotein lipase gene polymorphisms with coronary artery disease, J AM COL C, 33(4), 1999, pp. 1013-1020
Associations between a polymorphism in the gene encoding glycoprotein IIIaand myocardial infarction or coronary artery disease
Authors: Anderson, JL King, GJ Bair, TL Elmer, SP Muhlestein, JB Habashi, J Carlquist, JF
Citation: Jl. Anderson et al., Associations between a polymorphism in the gene encoding glycoprotein IIIaand myocardial infarction or coronary artery disease, J AM COL C, 33(3), 1999, pp. 727-733
Risultati: 1-25 | 26-29